Cargando…
Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study
PURPOSE: Brachytherapy (BT) and external beam radiation therapy (EBRT) are effective treatments for high-risk prostate cancer (PCa). However, the impact of these treatments on health-related quality of life (HRQL) remains unclear. In this study, we compared EBRT alone with EBRT plus a boost with hig...
Autores principales: | Martínez, Evelyn, Garin, Olatz, Pardo, Yolanda, Fernández, Pablo, Guix, Benjamin, Gutiérrez, Cristina, Boladeras, Ana, Ferrer, Ferran, Hernández, Tania, Ayala, Adriana, Egiguren, Mikel, Fernández, Gema, Muñoz, Víctor, Macías, Víctor, Pera, Joan, Pont, Àngels, Ferrer, Montserrat, Guedea, Ferran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117716/ https://www.ncbi.nlm.nih.gov/pubmed/34025730 http://dx.doi.org/10.5114/jcb.2021.103580 |
Ejemplares similares
-
Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study
por: Suárez, José Francisco, et al.
Publicado: (2022) -
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021) -
Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009) -
Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26
por: Zamora, Víctor, et al.
Publicado: (2023) -
Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
por: Verhaegen, Frank, et al.
Publicado: (2020)